Cite

HARVARD Citation

    Wallace, D. et al. (n.d.). OP0019 Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases. p. 59. [Online]. 
  
Back to record